UBS Group’s Alimera Sciences, Inc. ALIM Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-17,848
| Closed | -$99.2K | – | 9025 |
|
|
2024
Q2 | $99.2K | Buy |
+17,848
| New | +$99.2K | ﹤0.01% | 5035 |
|
|
2024
Q1 | – | Sell |
-2
| Closed | -$9 | – | 8801 |
|
|
2023
Q4 | $9 | Buy |
+2
| New | +$9 | ﹤0.01% | 7911 |
|
|
2019
Q3 | – | Sell |
-1,000
| Closed | -$13K | – | 7219 |
|
|
2019
Q2 | $13K | Buy |
+1,000
| New | +$13K | ﹤0.01% | 6036 |
|
|
2019
Q1 | – | Sell |
-231
| Closed | -$2K | – | 7192 |
|
|
2018
Q4 | $2K | Buy |
231
+55
| +31% | +$476 | ﹤0.01% | 6886 |
|
|
2018
Q3 | $3K | Sell |
176
-544
| -76% | -$9.27K | ﹤0.01% | 6750 |
|
|
2018
Q2 | $11K | Sell |
720
-22
| -3% | -$336 | ﹤0.01% | 6166 |
|
|
2018
Q1 | $11K | Buy |
742
+232
| +45% | +$3.44K | ﹤0.01% | 5935 |
|
|
2017
Q4 | $10K | Buy |
510
+459
| +900% | +$9K | ﹤0.01% | 6063 |
|
|
2017
Q3 | $1K | Buy |
+51
| New | +$1K | ﹤0.01% | 6676 |
|
|
2017
Q2 | – | Sell |
-187
| Closed | -$4K | – | 6909 |
|
|
2017
Q1 | $4K | Sell |
187
-62
| -25% | -$1.33K | ﹤0.01% | 6166 |
|
|
2016
Q4 | $4K | Buy |
+249
| New | +$4K | ﹤0.01% | 6363 |
|
|
2016
Q3 | – | Sell |
-101
| Closed | -$2K | – | 6886 |
|
|
2016
Q2 | $2K | Buy |
101
+88
| +677% | +$1.74K | ﹤0.01% | 6531 |
|
|
2016
Q1 | $0 | Sell |
13
-470
| -97% | – | ﹤0.01% | 6915 |
|
|
2015
Q4 | $17K | Buy |
483
+470
| +3,615% | +$16.5K | ﹤0.01% | 5692 |
|
|
2015
Q3 | $0 | Buy |
+13
| New | – | ﹤0.01% | 6981 |
|
|
2015
Q2 | – | Sell |
-118
| Closed | -$9K | – | 6921 |
|
|
2015
Q1 | $9K | Buy |
118
+83
| +237% | +$6.33K | ﹤0.01% | 5930 |
|
|
2014
Q4 | $3K | Buy |
+35
| New | +$3K | ﹤0.01% | 6528 |
|